Marron, T., Kodysh, J., Rubinsteyn, A., Finnigan, J., Blazquez, A., Saxena, M., Meseck, M., O'Donnell, T., Delbeau, D., Galsky, M., Doroshow, D., Miles, B., Misiukiewicz, K., Irie, H., Tiersten, A., Parekh, S., Posner, M., Wolf, A., Mandeli, J., Hammerbacher, J., Donovan, M., Brody, R., Gnjatic, S., Schadt, E., Friedlander, P., & Bhardwaj, N. (n.d.). 289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting. Journal for immunotherapy of cancer, 8, A316. http://access.bl.uk/ark:/81055/vdc_100144726459.0x000006